Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2019 · 10-Q
Revenue$229.35M$229.35M+8.7% vs Q1 2018 Net Income-$2.82M-$2.82MN/M vs Q1 2018 EPS Diluted-$0.05-$0.05N/M vs Q1 2018 Gross Profit$83,244,000−9.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$23,122,000−39.8% Free Cash Flowderived-$4,392,000N/M Margins · derivedGross margin36.3%−7.2 pt vs Q1 2018
Operating margin2.3%−5.6 pt vs Q1 2018
Net margin-1.2%−10.8 pt vs Q1 2018
ended Jun 30, 2018 · filed Aug 7, 2018 · 38 d after period end